Relipac 30Mg/5Ml Inj
₹1,650.00
Attributes
- Is Prescription Required
- Yes
- Is Returnable
- No
- Type
- Pharma
- Consume Type
- Parenteral
- Pack Size
- 5
- Cold Chain Product
- Yes
- Banned
- No
- Marketer Address
- Dhirubhai Ambani Life Sciences Centre, R-282, TTC Area of MIDC, Thane-Belapur Road, Rabale, Navi Mumbai 400 701
- Pack Form
- Vial
- Product Form
- Injection
- Unit Of Measurement
- ml
- Subcategory
- Neoplastic Disorders
- Manufacturer
- RELIANCE PHARMA
- Country Of Origin
- India
- Classifier 1
- NEOPLASTIC DISORDERS
- Classifier 2
- ANTI CANCER DRUGS
- Classifier 3
- ANTI CANCER DRUGS
- Restricted
- Yes
- Is Sensitive
- Yes
- Dosage Forms
- Injection
- Short Name
- Relipac 30Mg/5Ml Inj
- Unitprice
- ₹290.4 / 1 ml
- Dpco Drug
- No
Description
Key Benefits
Relipac 30Mg/5Ml Inj belongs to the group of anti-cancer medicines called anti-microtubule agents used to treat various types of cancers, including ovarian and breast cancer (in advanced/spreading state or after surgery) and advanced-stage non-small cell lung cancer. It may also be used when other treatments have failed or in combination with other treatments. Relipac 30Mg/5Ml Inj may also be indicated in patients with Kaposi’s sarcoma (cancer that develops from the cells that line lymph or blood vessels) associated with AIDS (Acquired Immuno-Deficiency Syndrome), where other treatments have not been effective. Relipac 30Mg/5Ml Inj contains ‘Paclitaxel’, which works by preventing the growth of certain cancer cells.
Directions for Use
Relipac 30Mg/5Ml Inj will be administered by a healthcare professional; do not self-administer.
Side Effects
- Nausea
- Vomiting
- Diarrhoea
- Hair loss
- Joint or muscle pain
- Decreased blood cell count
Storage
Store in a cool and dry place away from sunlight
Additional information
| Is Prescription Required | |
|---|---|
| Is Returnable | |
| Type | |
| Consume Type | |
| Pack Size | |
| Cold Chain Product | |
| Banned | |
| Marketer Address | |
| Pack Form | |
| Product Form | |
| Unit Of Measurement | |
| Subcategory | |
| Manufacturer | |
| Country Of Origin | |
| Classifier 1 | |
| Classifier 2 | |
| Classifier 3 | |
| Restricted | |
| Is Sensitive | |
| Dosage Forms | |
| Short Name | |
| Unitprice | |
| Dpco Drug |
